Cite

HARVARD Citation

    Büchser, D. et al. (n.d.). PD-0806 HDR-BT + SBRT for prostate cancer. QoL and toxicity analysis in a prospective phase II trial.. Radiotherapy and oncology. pp. S639-S640. [Online]. 
  
Back to record